Site icon OncologyTube

RECOURSE trial versus CORRECT and CONCUR trials evaluating regorafenib

Howard S Hochster, MD of Yale Medical Center discusses RECOURSE trial versus CORRECT and CONCUR trials evaluating regorafenib at ASCO GI 2016

Exit mobile version